Kleiner D, Horvath I, Bunduc S, Gergo D, Lugosi K, Fehervari P
Curr Neuropharmacol. 2023; 21(12):2505-2515.
PMID: 37519000
PMC: 10616923.
DOI: 10.2174/1570159X21666230727094431.
Okuda D, Kantor D, Jaros M, deVries T, Hunter S
Brain Commun. 2023; 5(1):fcad026.
PMID: 36861013
PMC: 9968651.
DOI: 10.1093/braincomms/fcad026.
Okuda D, Kantor D, Jaros M, deVries T, Hunter S
Brain Commun. 2022; 4(6):fcac300.
PMID: 36519155
PMC: 9732858.
DOI: 10.1093/braincomms/fcac300.
Wang S, Cheng H, Phillips P, Zhang Y
Entropy (Basel). 2020; 20(4).
PMID: 33265345
PMC: 7512770.
DOI: 10.3390/e20040254.
Hugos C, Cameron M
BMC Neurol. 2020; 20(1):368.
PMID: 33028236
PMC: 7541326.
DOI: 10.1186/s12883-020-01902-1.
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).
Grimaldi A, De Giglio L, Haggiag S, Bianco A, Cortese A, Crisafulli S
PLoS One. 2019; 14(7):e0219670.
PMID: 31361750
PMC: 6667203.
DOI: 10.1371/journal.pone.0219670.
Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies.
Akgun K, Essner U, Seydel C, Ziemssen T
J Cent Nerv Syst Dis. 2019; 11:1179573519831997.
PMID: 30886530
PMC: 6413425.
DOI: 10.1177/1179573519831997.
Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study.
Latino P, Castelli L, Prosperini L, Marchetti M, Pozzilli C, Giovannelli M
Neurol Sci. 2017; 38(10):1841-1848.
PMID: 28766025
DOI: 10.1007/s10072-017-3078-3.
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).
Messina S, Solaro C, Righini I, Bergamaschi R, Bonavita S, Bossio R
PLoS One. 2017; 12(8):e0180651.
PMID: 28763462
PMC: 5538735.
DOI: 10.1371/journal.pone.0180651.
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
Patti F, Messina S, Solaro C, Amato M, Bergamaschi R, Bonavita S
J Neurol Neurosurg Psychiatry. 2016; 87(9):944-51.
PMID: 27160523
PMC: 5013116.
DOI: 10.1136/jnnp-2015-312591.
